Cas:572-30-5 Avicularin manufacturer & supplier

Chemical Name:Avicularin

CAS.NO:572-30-5

Synonyms:4H-1-Benzopyran-4-one, 3-(α-L-arabinofuranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-;Fenicularin;2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl α-L-arabinofuranoside;Quercetin 3-α-L-arabinofuranoside;Avicularin;QUERCETIN-3-ARABINOSIDE;Avicularoside;Avicularine;Avicularin,Quercetin 3-alpha-L-arabinofuranoside

Molecular Formula:C₂₀H₁₈O₁₁

Molecular Weight:434.350

HS Code:

Physical and Chemical Properties:

Melting point:240-243ºC

Boiling point:855.4±65.0 °C at 760 mmHg

Density:1.9±0.1 g/cm3

Index of Refraction:1.802

PSA:190.28000

Exact Mass:434.084900

LogP:2.06

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 4H-1-Benzopyran-4-one, 3-(α-L-arabinofuranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Avicularin,Quercetin 3-alpha-L-arabinofuranoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4H-1-Benzopyran-4-one, 3-(α-L-arabinofuranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- Use and application,QUERCETIN-3-ARABINOSIDE technical grade,usp/ep/jp grade.

Related News: It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. Avicularin manufacturer It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. Avicularin supplier By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. Avicularin vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. Avicularin factory GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.